News
- Author:
- Randy Dotinga
Publish date: July 5, 2024
Over a mean 2.9 years, 13.4% of those who discontinued the drugs had another ischemic attack.
Article
- Author:
- Randy Dotinga
Publish date: June 26, 2024
Read More
News
- Author:
- Randy Dotinga
Publish date: June 25, 2024
Payments from the Accelerated and Advance Payment program will close for application in July.
News
- Author:
- Randy Dotinga
Publish date: June 14, 2024
A landmark new treatment for bleeding disorder banishes the need for transfusions, but it’s exorbitantly expensive.
News
- Author:
- Randy Dotinga
Publish date: June 11, 2024
Newly diagnosed, transplant-ineligible patients with multiple myeloma fare better when standard treatment gets a boost.
News
- Author:
- Randy Dotinga
Publish date: June 7, 2024
Outcomes improved across cohorts when venetoclax was added to ibrutinib, new analysis of phase-3 study finds.
News
- Author:
- Randy Dotinga
Publish date: June 6, 2024
Survival rises as tisagenlecleucel therapy reaches those with less severe disease, displacing HSCT.
News
- Author:
- Randy Dotinga
Publish date: June 3, 2024
Patients with Hodgkin lymphoma fared better on a less toxic alternative to gold-standard BrECADD therapy.
News
- Author:
- Randy Dotinga
Publish date: May 14, 2024
These patients have better outcomes, but less intense therapy isn’t yet pr...
News
- Author:
- Randy Dotinga
Publish date: May 6, 2024
AVAHO held a regional meeting in Seattle on May 4, 2024, that was entirely...
News
- Author:
- Randy Dotinga
Publish date: May 6, 2024
Reducing the high price of CAR T-cell therapy is a top priority worldwide, with new efforts underway in Asia and South America.
News
- Author:
- Randy Dotinga
Publish date: April 15, 2024
The early cancellation of a trial in southern India suggests that the use of antenatal steroids to prevent respiratory complications a...
News
- Author:
- Randy Dotinga
Publish date: April 12, 2024
There are over 450,000 people with a solid organ transplant living in the United States.
News
- Author:
- Randy Dotinga
Publish date: April 3, 2024
“In theory, if we can tell who is prone to develop MS or whose immune system might be reacting to EBV to cause MS, we can intervene early to preven...
News
- Author:
- Randy Dotinga
Publish date: April 3, 2024
Blood cancer conditions such as leukocytosis, tumor lysis syndrome, and differentiation syndrome can require urgent treatment.
